Opin vísindi

Smáæðabólga með rauðkyrningafjöld, EGPA, falinn fylgisjúkdómur astma? • Sjúkratilfelli •

Smáæðabólga með rauðkyrningafjöld, EGPA, falinn fylgisjúkdómur astma? • Sjúkratilfelli •


Titill: Smáæðabólga með rauðkyrningafjöld, EGPA, falinn fylgisjúkdómur astma? • Sjúkratilfelli •
Aðrir titlar: Eosinophilic small vessel vasculites (EGPA) a hidden severe asthma comorbitity
Höfundur: Sturluson, Olafur Orri
Pálsson, Ólafur
Hjaltested, Einar Kristinn
Lúðvíksdóttir, Dóra
Útgáfa: 2024-01-01
Tungumál: Íslenska
Umfang: 5
Háskóli/Stofnun: Landspítali
Deild: Læknadeild
Birtist í: Læknablaðið; 110(1)
ISSN: 0023-7213
DOI: 10.17992/lbl.2024.01.777
Efnisorð: Gigtarlæknisfræði; Háls- nef og eyrnaskurðlæknisfræði; Lungnalæknisfræði; EGPA; asthma; eosinophilic granulomatosis with polyangiitis; mepolizumab; Lung/diagnostic imaging; Churg-Strauss Syndrome/complications; Humans; Female; Aged; Asthma/drug therapy; Granulomatosis with Polyangiitis/complications; Almenn læknisfræði
URI: https://hdl.handle.net/20.500.11815/4720

Skoða fulla færslu

Tilvitnun:

Sturluson , O O , Pálsson , Ó , Hjaltested , E K & Lúðvíksdóttir , D 2024 , ' Smáæðabólga með rauðkyrningafjöld, EGPA, falinn fylgisjúkdómur astma? • Sjúkratilfelli • ' , Læknablaðið , bind. 110 , nr. 1 , bls. 28-32 . https://doi.org/10.17992/lbl.2024.01.777

Útdráttur:

A 72-year-old woman presented to the emergency department due to worsening dyspnea. She had been diagnosed with asthma a year earlier. At arrival, her oxygen saturation was only 84%. During lung auscultation, wheezing was noted over all lung fields. A blood test showed a significant increase in eosinophils in peripheral blood, highest value of 1.4 x 10E9/L. Further investigations in the respiratory ward showed a positive MPO-ANCA, which, together with clinical features of asthma, chronic rhinosinusitis with polyps, mononeuritis multiplex and eosinophilia, led to the diagnosis of eosinophilic granulomatosis with polyangiitis, or what used to be called Churg-Strauss syndrome. Corticosteroid treatment was initiated and subsequently tapered down when treatment with mepolizumab was started, which is an IL-5 inhibitor. Her symptoms quickly became much better. Frequent exacerbations and pulmonary symptoms became things of the past.

Athugasemdir:

Publisher Copyright: © 2024 Laeknafelag Islands. All rights reserved.

Skrár

Þetta verk birtist í eftirfarandi safni/söfnum: